2[1]The expert committee on the diagnosis and classification of dishetes.Mellitus.Report of the expert conanittee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,1997.20:1183-1197. 被引量：1
3[2]Guidelines Subcommittee.1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension[J].J Hypertens,1999,17(2):151-183. 被引量：1
4[3]Bernadet-Monrozies P,Rostaining L,Kamar N.et al.The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure[J].Presse Med,2002,31:1714-1720. 被引量：1
5[4]Woo KT,Lau YK,Chan CM,et al.ATRA therapy restoresnormalre-nal function and renal reserve and prevents renal failure[J].Ann Acad Med Singapore,2005,34:52-59. 被引量：1
6[5]Luno J,Praga M.The reno-protective effect of the dual blockade of the rennin angiotensin system(RAS)[J].Curr Pharm Des,2005,11:1291-1300. 被引量：1
7[7]Jacobsen P.Andersen S,Rossing k et al.Dualbiockade of the reninanglotensin system versusmaximal recommended dose of ACE inhibition in nephropathy[J].Nephral Dial Transplant,2002,17:1019-1024. 被引量：1
8Young MJ, Veves A, Smith JV,et al. Restoring lower limb blood flow improves conduction velocity in diabetie patients. Diabetologia, 1995,38 :1051-1054. 被引量：1
9Zoja C, Remuzzi G. Role of platelets in progrogressive glomerular disease. Pediatr Nephrol,1995. 495-502. 被引量：1
10Saeki S,Yamamura K,Matsushita M, et al. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation. Int J Clin Pharmaeol Ther, 1998,36:529. 被引量：1
